tm logo

Monitor this mark

View On USPTO

AMMONUL
Live/Registered
REGISTERED AND RENEWED

on 06 Oct 2023

Last Applicant/ Owned by

BAUSCH HEALTH IRELAND LIMITED

Citywest Business Campus

Dublin

IE

24

Serial Number

75876707 filed on 20th Dec 1999

Registration Number

2713864 registered on 06th May 2003

in the Principal Register

Correspondent Address

Jeremy Blackowicz

Jeremy Blackowicz

400 Somerset Corporate Blvd.

Bridgewater, NJ 08807

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

AMMONUL

intravenous preparations for the treatments of hyperammonemia of all origins

Classification Information

Class [005]
Pharmaceutical Products

intravenous preparations for the treatments of hyperammonemia of all origins

First Use Date in General

01st Feb 1998

First Use Date in Commerce

01st Feb 1998

Specimens

AMMONUL specimenAMMONUL specimenAMMONUL specimenAMMONUL specimen

Mark Details

Serial Number

No 75876707

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
06th Oct 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06th Oct 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06th Oct 2023REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
06th Oct 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12th Apr 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05th Apr 2023TEAS SECTION 8 & 9 RECEIVED
08th Feb 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
18th Jan 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
28th Dec 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
14th Dec 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY